Inventor · disambiguated record
Leland Shapiro
Also filed as: SHAPIRO LELAND
10 granted patents·23 pending applications·179 citations·filing 2000–2019
91Inventor score
Top patents by PatentIndex Score
33 records- 0194US8633305B2Compositions of, and methods for, alpha-1 anti trypsin Fc fusion moleculesSHAPIRO LELAND·Filed 2011·Granted Jan 21, 2014·37 cites·12 claims
- 0291US7850970B2Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infectionsUNIV COLORADO·Filed 2004·Granted Dec 14, 2010·29 cites·11 claims
- 0388US7807781B2Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infectionsUNIV COLORADO·Filed 2005·Granted Oct 5, 2010·5 cites·10 claims
- 0488US6489308B1Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditionsTRUSTEES OF UNIVERSITY OF TECH·Filed 2000·Granted Dec 3, 2002·53 cites·2 claims
- 0586US9499606B2Compositions of, and methods for, alpha-1 anti trypsin Fc fusion moleculesUNIV COLORADO REGENTS·Filed 2013·Granted Nov 22, 2016·5 cites·9 claims
- 0686US6849605B1Inhibitors of serine protease activity, methods and compositions for treatment of viral infectionsTRUSTEES OF UNIVERSITY TECHNOL·Filed 2000·Granted Feb 1, 2005·32 cites·4 claims
- 0784US8071551B2Methods and compositions for treating diabetesSHAPIRO LELAND·Filed 2008·Granted Dec 6, 2011·6 cites·7 claims
- 0883US9695229B2Compositions of, and methods for, alpha-1 antitrypsin Fc fusion moleculesTHE REGENTS OF THE UNIV OF COLORADO A BODY·Filed 2014·Granted Jul 4, 2017·4 cites·12 claims
- 0974US10913790B2Compositions of, and methods for, alpha-1 anti trypsin Fc fusion moleculesUNIV COLORADO REGENTS·Filed 2019·Granted Feb 9, 2021·0 cites·11 claims
- 1073US7704958B1Methods and compositions for inhibiting apoptosis using serine protease inhibitorsBIO HOLDING INC·Filed 2000·Granted Apr 27, 2010·8 cites·20 claims
- 1167US2010137192A1Compositions and methods for treating or ameliorating mycobacterial infectionsSHAPIRO LELAND·Filed 2009·Application pending·0 cites
- 1265US2009220518A1Methods and compositions for treatment of graft rejection and promotion of graft survivalUNIV COLORADO·Filed 2008·Application pending·0 cites
- 1363US2017240615A1COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN Fc FUSION MOLECULESUNIV COLORADO REGENTS·Filed 2017·Application pending·0 cites
- 1462US2004220239A1Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditionsFiled 2003·Application pending·0 cites
- 1562US2018133294A1Compositions and methods related to graft versus host disease and treatments thereofTHE UNIV OF COLORADO A BODY CORPORATE·Filed 2017·Application pending·0 cites
- 1662US2004220113A1Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditionsFiled 2003·Application pending·0 cites
- 1761US2010144630A1Compositions, methods and uses for inhibition and/or treatment of influenza infectionSHAPIRO LELAND·Filed 2009·Application pending·0 cites
- 1861US2004220242A1Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditionsFiled 2003·Application pending·0 cites
- 1961US2007224671A1Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditionsSHAPIRO LELAND·Filed 2003·Application pending·0 cites
- 2060US2009118162A1Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survivalUNIV COLORADO·Filed 2006·Application pending·0 cites
- 2156US2012045417A1Methods and compositions for islet cell preservationLEWIS ELI C·Filed 2011·Application pending·0 cites
- 2256US2012045460A1Methods and compositions for treatment of graft rejection and promotion of graft survivalLEWIS ELI C·Filed 2011·Application pending·0 cites
- 2355US2009298747A1Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical ConditionsBIO HOLDING INC·Filed 2009·Application pending·0 cites
- 2454US2011021416A1Compositions, methods and uses for treating bacterial infectionsSHAPIRO LELAND·Filed 2010·Application pending·0 cites
- 2553US2012040913A1Methods and compositions for treating diabetesSHAPIRO LELAND·Filed 2011·Application pending·0 cites
- 2650US2010210528A1Compositions, methods and uses for inhibition and/or treatment of influenza infectionSHAPIRO LELAND·Filed 2009·Application pending·0 cites
- 2750US2008051330A1Inhibitors of serine protease activity, methods and compositions for treatment of herpes virusesSHAPIRO LELAND·Filed 2006·Application pending·0 cites
- 2850US2011319330A1Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion InjurySHAPIRO LELAND·Filed 2010·Application pending·0 cites
- 2947US2008261869A1Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activitySHAPIRO LELAND·Filed 2008·Application pending·0 cites
- 3046US2009227518A1Compositions and methods for treating actin-mediated medical conditionsUNIV COLORADO·Filed 2006·Application pending·0 cites
- 3141US2007155681A1Methods and compositions for treatment of viral infectionsSHAPIRO LELAND·Filed 2005·Application pending·0 cites
- 3236US2012225813A1Compositions, methods and uses for treatment of type 1 diabetesLEWIS ELI C·Filed 2011·Application pending·0 cites
- 3330US2011201587A1Hsp90 inhibitors and methods of useBIO HOLDING INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leland Shapiro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →